Get notified when COCH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (worsened) — Accumulated deficit increased from $284.7M to $313.4M; auditor cites 'substantial doubt' about ability to continue as going concern despite February 2026 capital raise.
  • Material Weakness (worsened) — Material weaknesses in accounting personnel, risk assessment, policies/procedures, and IT controls remain unresolved for second consecutive year despite engaging advisory firm.
NASDAQ: COCH Envoy Medical, Inc. 10-K

Envoy completes 56-patient trial enrollment; raises $27.7M but burns cash, faces Nasdaq probation

Filed March 23, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read

Key Changes

  • high

    Completed enrollment of all 56 patients in pivotal Acclaim CI trial on March 10, 2026—first fully-implanted cochlear implant to reach full U.S. trial enrollment. FDA decision now expected in second half of 2027 (or H1 2028 if panel review required).

    MD&A: Clinical Milestones verify on EDGAR →
  • high

    Raised $27.7M net in February 2026 offering at $0.40/share, issuing 48M shares plus 120M warrants (exercise price $0.40) and 27M pre-funded warrants. Liquidity now extends into Q2 2027, but massive dilution looms if warrants exercise.

    MD&A: Capital Raises & Risk Factors: Warrants verify on EDGAR →
  • high

    Regained Nasdaq compliance in February 2026 after delisting notice, but now on one-year probation with 'more limited ability to cure' future deficiencies. Separately received new minimum-bid-price deficiency notice; stock traded as low as $0.36.

    Risk Factors: Nasdaq Compliance verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.

Partner

Trade COCH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 4, 2026 1:23 AM